Abstract:Objective:To investigate theneuropsychological changes after subthalamic nucleus deep brain stimulation(STN-DBS) in patients with Parkinson's disease (PD).Methods:From December 2014 to March 2016,42 patients diagnosed PD in Zhongnan Hospital of Wuhan University(21 received STN-DBS plus dopatherapy,21 received dopatherapy only) were recruited and assessed at both baseline and 6-month follow-up with Unified Parkinson Disease Rating Scale(activity of daily life,motor symptoms,drug complications),Addenbrooke's Cognitive Examination-Revised (orientation and attention,memory,verbal fluency,language and visuospatial ability),Hoehn-Yahr stage(disease stage),Schwab-England activity of daily life,Hamilton anxiety scale(anxiety) and Hamilton depression scale(depression) in the medication-on/stimulation-on condition.Changes between baseline and follow-up were compared by paired-t test or Wilcoxon signed rank test while changes between the two groups were compared by independent-t test or Mann-Whitney U test.Results:No significant change occurred in global cognition,while a slight decrease in verbal fluency during 6-month follow-up was detected (P=0.022).Compared with control group,STNDBS was related with motor symptoms(P =0.000),activity of daily life (P=0.047),depression (P=0.009),anxiety (P=0.003) improvement,as well as less anti-parkinsonism drug(P=0.000).Conclusion:STN-DBS is relatively safe with respect to cognition.Considering the improvement in activity of daily life,depression,anxiety and motor abilities,our study might give physicians positive guidance towards surgery treatment of advanced PD patients.

Effect of Subthalamic Nucleus Deep Brain Stimulation on Neuropsychological Outcomes in Parkinson's Disease Patients